相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum and Intracellular Detection of Cytokines in Patients Undergoing Chronic Hemodialysis
Dario Roccatello et al.
ARTIFICIAL ORGANS (2010)
Impact of catheter arteriography on the serum level of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase
Ugur Bozlar et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease
Seiji Ueda et al.
NEPHROLOGY (2007)
Disruption of methylarginine metabolism impairs vascular homeostasis
James Leiper et al.
NATURE MEDICINE (2007)
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: Ramipril versus valsartan
Mahmut Ilker Yilmaz et al.
BLOOD PURIFICATION (2007)
Pathogenesis and treatment of kidney disease and hypertension - The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine
MI Yilmaz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach
P Ravani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism
O Ozcan et al.
CLINICAL ENDOCRINOLOGY (2005)
Asymmetric dimethylarginine and progression of chronic kidney disease:: The mild to moderate kidney disease study
D Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Elevated plasma concentration of asymmetric dimethylarginine that is reduced by single dose testosterone administration in idiopathic hypogonadotropic hypogonadism patients
E Cakir et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Elevated urine neopterin levels in nonalcoholic steatohepatitis
H Yaman et al.
CLINICAL BIOCHEMISTRY (2005)
Asymmetrical dimethylarginine - The Uber marker?
JP Cooke
CIRCULATION (2004)
Associations between circulating inflammatory markers and residual renal function in CRF patients
R Pecoits et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Atherosclerotic renal artery stenosis: Epidemiology, cardiovascular outcomes, and clinical prediction rules
C Zoccali et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
Plasma pteridine concentrations in patients with chronic renal failure
K Yokoyama et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study
C Zoccali et al.
LANCET (2001)
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke
JH Yoo et al.
ATHEROSCLEROSIS (2001)
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
A Fard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Does ADMA cause endothelial dysfunction?
JP Cooke
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Serum neopterin as an objective marker of psoriatic disease activity
M Sánchez-Regaña et al.
ACTA DERMATO-VENEREOLOGICA (2000)
Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts
P Kotanko et al.
NEPHRON (2000)
Increased serum neopterin: a marker of coronary artery disease activity in women
X Garcia-Moll et al.
HEART (2000)
分享论文
